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Abstract
A low-molecular-weight Brucella abortus extract (a nucleotidelike material) inhibited zymosan-elicited
neutrophil degranulation and trichloroacetic acid-precipitable protein iodination (a measure of
myeloperoxidase and 8 20 2 release from neutrophilic leukocytes). Inhibition of neutrophU function was
directly related to the concentration of the Brucella extract. The extract preferentially inhibited degranulation
of primary (azurophUic or peroxidase positive) granules and had limited inhibition of secondary (specific or
peroxidase negative) granule release but did not inhibit opsonized zymosan ingestion. Inhibition of protein
iodination closely paralleled that of primary granule release but was unrelated to inhibition of secondary
granule release. These results suggest that B. abortus has a component which is capable of inhibiting release of
myeloperoxidase by dose-dependent preferential inhibition of primary granule release from bovine
neutrophilic leukocytes.
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A low-molecular-weight Brucella abortus extract (a nucleotideHke material) inhibited zymosan-elicited 
neutrophU degranulation and trichloroacetic acid-precipitable protein iodination (a measure of myeloperox-
idase and 8 20 2 release from neutrophilic leukocytes). Inhibition of neutrophU function was directly related to 
the concentration of the Brucella extract. The extract preferentially inhibited degranulation of primary 
(azurophUic or peroxidase positive) granules and had limited inhibition of secondary (specific or peroxidase 
negative) granule release but did not inhibit opsonized zymosan ingestion. Inhibition of protein iodination 
closely paralleled that of primary granule release but was unrelated to inhibition of secondary granule release. 
These results suggest that B. abortus has a component which is capable of inhibiting release of myeloperoxidase 
by dose-dependent preferential inhibition of primary granule release from bovine neutrophUic leukocytes. 
The ability of neutrophils to phagocytize and then kill 
ingested bacteria is critical for mammalian resistance to 
pathogenic Inicrobes. Facultative intracellular bacteria such 
as Mycobacterium tuberculosis, Brucella abortus, and 
Listeria monocytogenes have evolved mechanisms to cir-
cumvent these processes. A wide variety of virulence factors 
which alter phagocytic cell function have been discussed (9). 
Included with these factors are a cell wall component of B. 
abortus (20, 21) and sulfolipids of M. tuberculosis (12, 13). 
The demonstrated effector molecule is frequently secreted or 
located on the bacterial surface which is first exposed to the 
phagocytic cell. 
B. abortus is ingested by neutrophils but does not stimu-
late the oxidative burst (20). It inhibits neutrophil degranula-
tion and is resistant to some granule-released antimicrobial 
enzymes (24). However, B. abortus is sensitive to the 
myeloperoxidase-H20rhalide system (20). A cell wall-
associated lipopolysaccharide has been proposed as the cell 
wall component that is the key virulence factor which 
inhibits neutrophil degranulation (20, 21). Recently, a 
nucleotidelike compound has been isolated from the surface 
of virulent B. abortus and is capable of inhibiting protein 
iodination (a measure of the myeloperoxidase-H20rhalide 
pathway) by bovine neutrophils (7). The protein iodination 
reaction is dependent on a number of neutrophil processes 
including phagocytosis, production of H20 2, release of 
myeloperoxidase from primary granules, and the presence of 
halide ions (19). The B. abortus extract did not inhibit 
Staphylococcus aureus phagocytosis or superoxide anion 
production, but it does inhibit the iodination reaction. Since 
adequate amounts of protein and iodide were present, it was 
speculated that the reduced iodination was a result of 
Brucella extract-mediated inhibition of degranulation. 
For intracellular degranulation to occur, the membranes of 
the phagosome and lysosome must fuse. Release of granule 
enzymes for the activation of oxygen-dependent (myeloper-
oxidase-H202-halide system) or oxygen-independent 
* Corresponding author. 
t Present address: Department of Veterinary Pathobiology, Uni-
versity of Illinois, Urbana, IL 61801. 
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(proteases, cationic proteins, phospholipase A~ pathways is 
necessary for Inicrobicidal activity by the neutrophil (1, 28). 
Neutrophil degranulation is inhibited by exogenous cAMP, 
cAMP analogs, and various agents which increase intracel-
lular cAMP levels (10, 15, 17, 18). Most studies have shown 
that primary and secondary granule release is inhibited by 
these materials. 
Secretion of both primary and secondary granules is 
promoted by opsonized zymosan (16). Secondary granules 
of rabbit neutrophils degranulate as early as 30 s after 
phagocytosis, and primary granules degranulate 1 to 3 Inin 
after phagocytosis (3). Preferential degranulation of second-
ary granules has been demonstrated with phorbol myristate 
acetate or the ionophore A23187 (30). The purpose of this 
study was to exainine the ability of a nucleotidelike material 
isolated from B. abortus (7) to inhibit bovine neutrophil 
degranulation and to determine whether there was any 
preferential inhibition of primary or secondary granule re-
lease from neutrophilic leukocytes. 
MATERIALS AND MEmODS 
Preparation of B. abortus and Brucella extract. Bacteria for 
extract isolation were prepared as previously described (7). 
B. abortus 2308 (a highly virulent, smooth form of bovine 
origin) was grown in a fermentor for 48 h at 37°C. The 
bacteria were harvested by filtration and washed three times 
with sterile 0.85% saline by centrifugation. They were heat 
killed at 65°C for 60 min and pelleted by centrifugation at 
18,000 x g for 20 min. Supernatant from the heat-killed 
bacteria was collected and separated into two fractions by 
molecular filtration (YM2 filters; Ainicon Corp., Lexington, 
Mass.). The YM-2 filter has a nominal molecular mass cutoff 
of 1,000 daltons, a clear water flow of 0.02 to 0.035 mVcm2 
per min at a pressure of 3.8 kg/cm2, and a solute rejection of 
40% for sucrose, 65% for raffinose, and 80% for inulin 
(Ainicon). Material retained by the filter was considered as 
having a molecular mass greater than 1,000 daltons, and the 
filtrate was arbitrarily designated as less than 1,000 daltons. 
The filtered extract was separated by high-performance 
liquid chromatography to remove salts and lyophilized to 
remove volatile ·buffer components. The remaining dried 
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286 BERTRAM ET AL. 
material was weighed directly, and the active components 
contained no detectable lipids or proteins (7). The extract 
passing through the 1,000-dalton molecular mass filter was 
tested at three concentrations. 
Neutrophll leukocyte preparation. Four adult Holstein-
Friesian steers, serologically negative for B. abortus, were 
used as a source of polymorphonuclear leukocytes (PMNs) 
for this study. Bovine PMNs were isolated as previously 
described (25). Peripheral blood was collected in acid-
citrate-glucose solution and centrifuged. The resulting 
plasma and buffy-coat cells were aspirated and discarded, 
and erythrocytes present in the packed cell layer were lysed 
with hypotonic phosphate-buffered, deionized water. 
,Isotonicity. was restored to the remaining cells (90% or 
greater being granulocytes) by addition of phosphate-
buffered (0.0132 M, pH 7.2) 2.7% saline (PBS). Granulocytes 
were washed, resuspended in PBS to a concentration of 5 x 
107 cells per ml, and held at room temperature for approxi-
mately 1 h before use. 
PMN function test. The iodination assay (19, 25) was 
conducted in duplicate, and the average of duplicate values 
was used for calculations. The assay (a measure of the 
myeloperoxidase-H20rhalide system of PMNs) was per-
formed in capped polystyrene tubes (12 by 75 mm). The 
standard reaction mixture contained 0.05 ml ofPMNs (2.5 x 
106 cells), 0.05 JJ.Ci of 1251 (carrier-free; Amersham Corp., 
Arlil\gton Heights, Ill.), 40 nmol ofNal, 0.05 ml ofpreopson-
ized zymosan (10 mg/ml), and 0.3 ml of Earle balanced salt 
solution. Results were standardized and expressed as 
nanomoles of Nal per 107 PMNs per hour. One hundred 
microliters of each of the three different Brucella extract 
concentrations was added to the standard reaction mixture, 
resulting in final Brucella fraction concentrations of 0.04, 
0.16, and 0.32 mg/ml (wt/vol). The approximate number of 
bacteria required to produce each concentration was 2.5 x 
1()9/ml (0.04 mg/ml), 1 X 1010/ml (0.16 mg/ml), and 2 X 
1010/ml (0.32 mg/ml). This extract was collected from killed 
cells only, but B. abortus may be able to release the 
materials present in the extract without cell lysis and death 
(7). To determine the total possible degranulation and iodina-
tion in the test system, 100 JJ.l of PBS was added to the 
mixture instead of Brucella extract. To determine the mini-
mum level of iodination and degranulation in the system, no 
zymosan was added to the reaction mixture (unstimulated 
neutrophils). The reaction in each test group was allowed to 
proceed for 20 min at 37°C, and the amount of trichloroacetic 
acid-precipitable radioactivity was determined. Results were 
expressed as nanomoles of Nal per 107 PMNs per hour. 
Sample preparation for electron microscopy. Duplicate 
samples for electron microscopic examination were pre-
pared simultaneously with samples for the iodination assays. 
Sodium iodide was used in place of Na1251 for electron 
microscopic samples. At the end of the 20-min incubation 
period, cold WC) 2.5% glutaraldehyde in 0.1 M cacodylate 
buffer was added to the reaction mixture, and fixation was 
allowed to proceed for 3 h: Neutrophils were fixed while in 
suspension and at 4°C so microtubules would depolymerize 
and the cells would become spherical. Samples were then 
postfixed in 1.0% Os04 for 30 min, dehydrated in graded 
alcohols, cleared in propylene oxide, embedded, and poly-
merized in resin. Ultrathin sections were cut at 70 to 90 nm 
and stained with uranyl acetate and lead citrate. 
Identification of primary granules was done as previously 
reported (22). Neutrophils were fixed in 2.5% glutaralde-
hyde, washed in cacodylate buffer, and suspended in the 
peroxidase substrate of Graham and Karnovsky (14). Perox-
INFECT. IMMUN. 
TABLE 1. Abbreviations used to describe morphometric analysis 
of neutrophilic leukocytes 
Abbrevia-
tion Definition 
V v ..... Relative volume percent of the given neutrophil structure 
expressed as a percentage of the given neutrophil, 
e.g., Vv ... Vv58, etc. 
V ...... Absolute volume of the neutrophil or organelle ex-
pressed in cubic micrometers, e.g., V ... v ••. etc. 
ag .... Primary granules (peroxidase positive) 
sg .... Secondary and large granules (peroxidase negative) 
tg .... All granules (peroxidase positive and peroxidase nega-
tive) 
pi . . . . Phagolysosomes containing zymosan 
TC ... Total points, area, or volume for the neutrophilic leuko-
cyte minus the respective measurement for the 
zymosan-containing phagolysosomes 
idase-positive granules contained an electron-dense enzyme-
substrate precipitate. 
Morphometric analysis. Analysis was conducted as previ-
ously described (4, 6, 29). Six to 10 blocks were made, and 
1 block was randomly chosen from each duplicate sample. 
Ten photomicrographs were obtained by random systematic 
subsampling at a magnification of x6,900. Photographs were 
made at a final magnification of x 18,000. For morphometric 
analysis, a point count lattice (121 points) was superimposed 
on photographs, and points falling on phagolysosome, nu-
cleus, and primary (peroxidase positive) and secondary 
(peroxidase negative) granules were recorded. Points on 
other structures within the neutrophil were also recorded for 
determining total cell points. The percentage of the 
neutrophil occupied by each of these structures was calcu-
lated as previously described (4, 6, 29). If the total cell points 
(excluding those on phagolysosomes) are used as the refer-
ence compartment, point-to-point ratios of a given organelle 
to the total cell will be the relative volume percent (Vv) of 
that organelle within that cell (6, 29). Abbreviations used to 
describe morphometric data are found in Table 1. 
To determine absolute areas for absolute volume determi-
nation, neutrophil and nuclear profile areas were measured 
by semiautomatic, computerized morphometry (Bioquant II; 
R&M Biometrics, Nashville, Tenn.). Since neutrophils were 
induced to become spherical, mensuration coefficients can 
be used to calculate the actual volume of a neutrophil from 
the cross-sectional area (28) by the following equations: 
and 
'frlY 
A,.= - 4- (1) 
'frlY 
Vyc = --
6 
(2) 
where A,. is the cross-sectional area of the neutrophil, D is 
the diameter of the neutrophil, and Vyc is the neutrophil 
volume. By multiplying the actual neutrophil volume (VTC) 
by the volume percent (V v) of a given organelle, the actual 
volume (V) for that organelle can be determined (4, 6, 29). 
The relative volume percent of primary granules (Vv..,J 
was determined on peroxidase-labeled, unstained thin sec-
tions. These sections were then stained with uranyl acetate 
and lead citrate, and the relative volume percents of all 
granules (Yvtg) and of the zymosan-containing phagosomes 
(Yvp.> were determined. The relative volume of secondary 
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VoL. 52, 1986 INHIBITION OF NEUTROPHIL DEGRANULATION 287 
TABLE 2. Iodination and granule volumes of neutrophils exposed to Brucella extracta 
Iodination (nmol of Vol (IJ.m3) 
Group Naii!O'PMN 
v d V .. = V,. ratio' per h)6 v c v. .. .. .. 
Unstimulated 3.2 ± 0.1 49.8 ± 3.7 9.8 ± 1.5 40.1 ± 1.5 0.24:1 
Saline + zymosan 31.8 ± 3.3 32.1 ± 4.7 7.2 ± 1.4 24.9 ± 3.3 0.28:1 
Brucella extract + zymosan at: 
0.04 mg/ml 28.5 ± 3.2 31.1 ± 2.8 5.4 ± 0.3 25.6 ± 2.6 0.21:1 
0.16 mg/ml 20.4 ± 0.46 40.3 ± 6.1 9.1 ± 0.66 31.1 ± 5.5 0.29:1 
0.32 mg/ml 18.6 ± 1.36 42.8 ± 3.36 11.5 ± 1.36 31.3 ± 2.4 0.37:1 
• Each value is the mean :t the standard error of the mean for four animals, each conducted in duplicate. 
6 Slope, -41.1 (P < 0.01). 
c V18, Total granule volume; slope= 38.1 (P < 0.05). 
d V ... Primary granule (peroxidase positive) volume; slope = 16.9 (P < 0.01). 
• V ,., Secondary granule (peroxidase negative) volume; slope = 21.2 (not significant). 
I Slope not determined . 
• p < 0.05. 
granules was calculated by: 
Yvta - Yv1111 = Yvs1 (3) 
where Yvsa is the relative volume of secondary granules. 
Inhibited degranulation of all granules was calculated as a 
percentage of PBS-treated neutrophil V ta<V tgls) by: 
[(Vtg~p - Vtg~5)!Vtg~5] x 100 (4) 
where V tglp is the V ta of the given principal group. Inhibited 
degranulation of primary granules was calculated as a per-
centage of PBS-treated neutrophil V 1111(V aa~J by: 
[V agtp - V agt8)/V agts] X 100 (5) 
where V agtp is the V 1111 of a given principal group. Inhibited 
degranulation of secondary granules was calculated as a 
percentage of PBS-treated neutrophil v., (V.g~J by: 
(6) 
where Ysgtp is the v., of any given principal group. The ratio 
of primary to secondary granule volumes was calculated by: 
V agtp/Ysgtp (7) 
Statistical analysis. Linear regression analysis was used to 
statistically determine the influence of Brucella fraction 
concentration on protein iodination, granule volume, and 
percent inhibition of neutrophil degranulation. All slopes 
were tested against the hypothesis that there was no differ-
ence from zero. Student's t test was used to statistically 
determine differences between groups in the volume of 
zymosan-containing phagolysosomes and primary and sec-
ondary granules. 
RESULTS 
Inhibition of granule release. Unstimulated neutrophilic 
leukocytes were considered to have the maximal granule 
volume possible for animals in these experiments and to 
have released no granules. Granule volume (V ta> represented 
26% of the neutrophil volume (VTd. with most of that being 
peroxidase-negative (secondary) granules (Table 2). Neutro-
phils exposed to saline and opsonized zymosan were con-
sidered to have the maximal amount of degranulation possi-
ble with our test system and 0.0% inhibition of granule 
release. The number of granule profiles was markedly re-
duced compared with unstimulated neutrophils, and the total 
granule volume (Vta> was 10% of the neutrophil volume (VTd 
(Table 2). The volume ratio of primary (V ...> to secondary 
(V.g) granules was greater in neutrophils exposed to saline 
and zymosan than that seen in unstimulated neutrophils 
(Table 2). Approximately 36% of the volume of all granules 
(V ta> was released from neutrophils in this group. Most of the 
released granule volume was the result of secondary granule 
release (Table 2). Neutrophils exposed to the Brucella ex-
tract and opsonized zymosan had significant (P < 0.002) 
concentration-dependent inhibition of primary granule re-
lease, and inhibition of primary granule release was greatest 
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FIG. 1. Percent inhibition of primary (peroxidase positive), sec-
ondary (peroxidase negative), and total neutrophil granule release. 
The slopes for inhibition of total neutrophil granule release 
(157 .2%/mg per ml of Brucella extract) and secondary granule 
release (104.4%/mg per ml of Brucella extract) are not statistically 
significant; that of primary granule release (344.3%/mg per ml of 
Brucella extract) is significant at P < 0.002. 
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288 BERTRAM ET AL. INFECT. IMMUN. 
FIG. 2. Unstimulated bovine neutrophilic leukocyte peroxidase labeled but without uranyl acetate and lead citrate staining. The neutrophil 
is round with few short cytoplasmic projections. The nucleus (N) is bilobed and composed primarily of heterochromatin. Primary or 
azurophilic (peroxidase positive) granules (AG) have a punctate, electron-dense precipitate from the peroxidase-substrate reaction. 
Secondary or specific (peroxidase negative) granules (SG) are large, round, ovoid to oblong, and slightly electron dense. Bar = 1.0 IJ.m. 
in neutrophils treated with 0.32 mg of Brucella extract per ml 
and zymosan (Fig. 1). 
Morphometry of neutrophilic leukocyte granules. Neutro-
philic leukocytes exposed to the lowest extract concentra-
tion had granule volumes similar to those in neutrophils 
exposed to saline and zymosan (Table 2). The ratio of 
primary (Vag) to secondary (V5g) granule volume in neutro-
phils exposed to 0.16 mg of Brucella extract per ml was 
greater than that in unstimulated neutrophils. The volume of 
primary granules <Vag) was greater (P < 0.05), but the 
volume of secondary granules (V5g) was not different (P > 
0.05) from that in neutrophils treated with saline and 
zymosan (Table 2). Neutrophils exposed to 0.32 mg of 
Brucella extract per ml had a greater V1g than saline-treated 
neutrophils but less than that in unstimulated neutrophils. 
The volume of primary (Vag) granules was significantly (P < 
0. 05) greater, but the volume of secondary granules (V sg) was 
not significantly (P > 0.05) different from that of neutrophils 
treated with saline and zymosan. The volume ratio of 
primary <Vag) to secondary <Vsg) granules in this group was 
greater than that from neutrophils treated with 0.16 mg of 
Brucella extract per ml and zymosan (Table 2). 
NeutrophUic leukocyte morphology. Unstimulated neutro-
philic leukocytes were round with few cytoplasmic projec-
tions (Fig. 2). Granules were located in and around the 
centrosome and separated from the plasma membrane by a 
thin rim of organelle-free cytoplasm. In peroxidase-labeled, 
unstained sections, peroxidase-positive (primary) granules 
had a punctate, electron-dense precipitate which was con-
fined to the granule cross-sectional profile (Fig. 3). These 
granules were variably sized, round to oblong, and randomly 
distributed in the cell. The average cut surface area (mean ± 
the standard error of the mean) of neutrophils was 40.7 ± 1.1 
1J.m2 and 4.5 ± 0.3 IJ.m2 for the nucleus, which gave the 
mensuration values in Table 3. 
Neutrophilic leukocytes exposed to saline and opsonized 
zymosan were round to ovoid and had multiple pseudopodia. 
The average neutrophil profile area was 42.8 ± 2.3 IJ.m2, and 
the nucleus profile area was 4.1 ± 0.1JLm2 (Table 3). One to I 
several phagolysosomes were in most neutrophils, and each 
contained one to several zymosan particles. The mean 
volume of phagolysosomes (Vp1) was not statistically greater 
than that of those from Brucella extract-treated neutrophils 
(Table 3). 
Neutrophils exposed to the lowest concentration (0.04 
mg/ml) of Brucella extract had a neutrophil cross-sectional 
area of 44.3 ± 2.4 JLm2 and a nuclear cross-sectional area of 
4.4 ± 0.7 JLm2 (Table 3). Neutrophils--had - multiple 
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VOL. 52, 1986 INHIBITION OF NEUTROPHIL DEGRANULATION 289 
FIG. 3. Unstimulated bovine neutrophilic leukocyte, peroxidase labeled but without uranyl acetate or lead citrate staining. Primary or 
azurophilic (peroxidase positive) granules (AG) are round to ovoid, smaller than secondary granules, and have a punctate electron density. 
Both primary and secondary granules are randomly distributed. Bar = 1 IJ.m. 
pseudopodia and reduced granulation (Fig. 4). Phagolyso-
somes containing one to several zymosan particles had a 
volume (V~1) of 3.8 11-m3 , which was not significantly greater 
than that in the other groups. 
Neutrophils exposed to 0.16 mg of Brucella extract per ml 
and zymosan had an average neutrophil cross-sectional area 
of 44.4 ± 2.4 1J.iD2 and a nuclear cross-sectional area of 4.3 ± 
0.6 11-m2 (Table 3). One to several zymosan-containing 
phagolysosomes were present in most neutrophils. The 
volume of zymosan-containing phagolysosomes (Vp1) was 
not statistically different from that in the other groups (Table 
3). Granules were polarized, with most located away from 
and a few juxtaposed to phagolysosomes. 
Neutrophils exposed to 0.32 mg of Brucella extract per ml 
and zymosan had an average cross-sectional area of 45.7 ± 
0.8 11-m2 and a nuclear cross-sectional area of 4.0 ± 0.3 11-m2 
(Table 3). Phagolysosome volume (Vp1) was not significantly 
different (Table 3) from that in the other groups, and there 
was no significant concentration effect on this volume (P > 
0.41). Some granules had a flocculent matrix and a cross-
sectional profile similar to that of primary granules (Fig. 5). 
Protein iodination. Neutrophilic leukocytes exposed to 
saline and opsonized zymosan were considered to have the 
maximal amount of protein iodination (myeloperoxidase-
H20rhalide activity) possible with our test system. A con-
centration-dependent decrease in iodination was present in 
neutrophils exposed to the Brucella extract, and this de-
crease paralleled the inhibition of primary granule release. 
At the two highest concentrations of extract, protein iodina-
tion was significantly less than that in neutrophils exposed to 
saline and zymosan only. 
DISCUSSION 
Preferential inhibition of primary granule release from 
bovine neutrophils by Brucella extract Was dose dependent. 
The influence of Brucella extract concentration on granule 
volume, the ratio of primary to secondary granule volume, 
and the inhibited release of primary granules suggests that 
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290 BERTRAM ET AL. INFECT. IMMUN. 
FIG. 4. Bovine neutrophilic leukocyte exposed to 0.04 mg of B. abortus extract per ml and stained with uranyl acetate and lead citrate. 
The cell is round with few thick pseudopodia. The phagolysosome contains a zymosan particle (Z). Cytoplasmic granules are reduced in 
number (compare with Fig. 5), and few granules are primary; most are secondary (specific) granules. Granules are separated from the 
phagosome by a zone of microfilaments (M). 
preferential inhibition of neutrophil degranulation was dose 
dependent. Phorbol myristate acetate and ionophore A23187 
cause preferential release of neutrophil secondary granules 
(11, 30) by their ability to increase cellular levels of cGMP 
(11). The increase in cellular cyclic nucleotides is seen only 
after a period of phorbol myristate acetate-neutrophil incu-
bation (11). Activity of the Brucella extract used in the 
present study has been attributed to nucleotidelike com-
TABLE 3. Mensuration values for neutrophils exposed to Brucella extract• 
Diameter (iJ.m) of: Vol (1J.m3) of: 
Group Neutrophil Phagolysosome Neutrophil Phagolysosome 
(DTc) (Dpt) (VTc) (Vpt) 
Unstimulated 7.2:!: 0.1 0.0 193.5 :!: 8.0 0.0 
Saline + zymosan 7.4 :!: 0.3 1.97 :!: 0.1 213.7 :!: 14.0 4.1:!: 0.7 
Brucella extract + zymosan at: 
0.04 mglml 7.5:!: 0.2 1.75 :!: 0.3 216.9:!: 16.5 3.8:!: 2.2 
0.16 mg/ml 7.6:!: 0.2 1.81 :!: 0.1 226.9:!: 15.0 3.1:!: 0.2 
0.32 mg/ml 7.6:!: 0.1 1.73 :!: 0.1 227.3 :!: 15.9 2.8:!: 0.5 
• Each value is the mean ± the standard error of the mean for four animals, each conducted in duplicate. 
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VoL. 52, 1986 INHIBITION OF NEUTROPHIL DEGRANULATION 291 
FIG. 5. Bovine neutrophilic leukocyte expose<i to 0.32 mg of B. abortus extract per ml and stained with uranyl acetate and lead citrate. 
A zymosan particle (Z) is focally digested. The cell has more primary granules than the cell in Fig. 4. Numerous ftocculent granules (F) 
correspond to primary granules. Some granules are juxtaposed to the phagosome. 
pounds (7), and in the present study its inhibitory effects 
occurred without a preincubation period with the neutrophil. 
This immediate effect on neutrophils suggests the Brucella 
fraction works at a different cellular location· than phorbol 
myristate acetate or directly substitutes for a nucleotide that 
may control neutrophil granule release. Purine nucleotides 
and modified analogs inhibit zymosan-stimulated lysosomal 
secretion from macrophages (23). This Brucella fraction may 
be part~ally responsible for the inhibition of neutrophil 
degranulation seen with live B. abortus (20). 
Reduced neutrophil degranulation and preferential inhibi-
tion of primary granule release are not explained by inhibi-
tion of zymosan phagocytosis. Phagolysosomal volumes 
were reduced in a dose-dependent manner for each of the 
Brucella-treated groups, but this reduction was not statisti-
cally significant. Furthermore, Brucella extract does not 
inhibit ingestion of Staphylococcus aureus by bovine neu-
trophils (7). Inhibition of protein iodination could be the 
result of inhibited neutrophil myeloperoxidase activity, but 
this is not likely since similar concentrations of Brucella 
extract did not reduce in vitro peroxidase activity (7). 
Preferential inhibition of primary granule release suggests 
that different mech(lnisms control release of the two granule 
types from bovine neutrophils. Granules are released from 
rabbit neutrophils at different times during the process of 
degranulation (3). The sequential release is coordinated with 
a pH change in the phagosome which provides optimal 
activity of the granule enzymes. These and other (11, 30) 
observations support the notion that there is selective con-
trol of neutrophil degranulation, yet most inhibitors of 
degranulatio'n block both primary and secondary granule 
release (10, 15, 17, 18, 31). The preferential inhibition of 
primary granule release by Brucella extract was concentra-
tion dependent. This suggests that the ~xtract inhibits a 
different pathway from that which controls secondary gran-
ule release or has a dose-<J~pendent ejfect on the same 
pathway that controls release of both granules from neutro-
phils. 
B. abortus is phagocytized by neutrophils without activa-
tion of the hexose monophosphate pathway (20) and inhibits 
neutrophil degranulation (24). A cell waU component, possi-
bly lipopolysaccharide, was proposed as the mediator of 
these effects on human and guinea pig neutrophils (24). The 
concentrations of Brucella fraction used in our study have 
been demonstrated to inhibit the protein iodination reaction 
of bovine neutrophils, and this same activity has been 
demonstrated with live B. abortus (7). Results of the present 
study demonstrate that this fraction also preferentially inhib-
its neutrophil primary granule release. These studies indicate 
that B. abor(us has at least two components which inhibit 
neutrophil degranulation: a lipopolysaccharide (20, 21) and a 
nucleotidelike material. Similar results as those obtained in 
the present study could be obtained with a lipopolysaccha-
ride preparation if it were contaminated with the nucleotide-
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292 BERTRAM ET AL. 
like material. The B. abortus extract used in the present 
study did not contain lipopolysaccharide or lipid A (7). 
Which, if any, of these Brucella fractions is the most 
significant biologically was not established. Since the Bru-
cella extract used in the present study has been demon-
strated in extracellular media of live B. abortus (7), it would 
likely reduce the ability of neutrophils to kill B. abortus if it 
were released in vivo. 
Protein iodination is an in vitro assay for the myeloperox-
idase-H20rhalide antibacterial system of the neutrophilic 
leukocyte (5, 7, 8, 27). In the conditions used in the present 
study, this assay closely correlates with primary (peroxidase 
positive) granule release from bovine neutrophils. This sug-
gests that primary granule release is a rate-limiting step in 
the myeloperoxidase-H20rhalide pathway. This also sug-
gests that secondary and large (2) (peroxidase negative) 
granules of the bovine neutrophil do not participate in the 
protein iodination reaction. Iodination can be inhibited with-
out inhibition of nitroblue tetrazolium reduction (26), sug-
gesting that the rate-limiting step in the iodination reaction is 
myeloperoxidase (from primary granules) and not oxidative 
metabolism. By combining these two assays in our study, we 
demonstrated that a B. abortus component is capable of 
preferentially inhibiting primary granule release. 
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